LLY

1,005.68

-2.31%↓

JNJ

246.52

-0.84%↓

ABBV

233.45

-0.34%↓

NVS

163.49

-2.3%↓

MRK

120.61

-1.12%↓

LLY

1,005.68

-2.31%↓

JNJ

246.52

-0.84%↓

ABBV

233.45

-0.34%↓

NVS

163.49

-2.3%↓

MRK

120.61

-1.12%↓

LLY

1,005.68

-2.31%↓

JNJ

246.52

-0.84%↓

ABBV

233.45

-0.34%↓

NVS

163.49

-2.3%↓

MRK

120.61

-1.12%↓

LLY

1,005.68

-2.31%↓

JNJ

246.52

-0.84%↓

ABBV

233.45

-0.34%↓

NVS

163.49

-2.3%↓

MRK

120.61

-1.12%↓

LLY

1,005.68

-2.31%↓

JNJ

246.52

-0.84%↓

ABBV

233.45

-0.34%↓

NVS

163.49

-2.3%↓

MRK

120.61

-1.12%↓

Search

VistaGen Therapeutics Inc

Abierto

0.58 -3.33

Resumen

Variación precio

24h

Actual

Mínimo

0.57

Máximo

0.58

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+64.41% upside

VistaGen Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

2 mar 2026, 23:41 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Nikkei May Decline on Concerns About Energy Prices -- Market Talk

2 mar 2026, 23:37 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Higher Amid Middle East Conflict -- Market Talk

2 mar 2026, 23:26 UTC

Noticias de Eventos Importantes

How the Iran Conflict Could Pressure Consumer Staples Companies -- Barrons.com

2 mar 2026, 22:41 UTC

Charlas de Mercado

Australian Reits Wait on Recovery in Trading Multiples -- Market Talk

2 mar 2026, 22:32 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

2 mar 2026, 22:32 UTC

Charlas de Mercado

RBA Cautious About Potential for Energy Supply Shocks -- Market Talk

2 mar 2026, 22:21 UTC

Charlas de Mercado

Port of Tauranga's Upgraded Profit View Still Looks Conservative -- Market Talk

2 mar 2026, 22:11 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

2 mar 2026, 22:11 UTC

Charlas de Mercado

Don't Lose Sight of Bigger Picture With Summerset -- Market Talk

2 mar 2026, 22:10 UTC

Adquisiciones, fusiones, absorciones

IAC Is Near Deal to Sell Care.com to Private-Equity Firm -- WSJ

2 mar 2026, 22:06 UTC

Charlas de Mercado

Channel Infrastructure's Dividend Positively Surprises -- Market Talk

2 mar 2026, 22:00 UTC

Charlas de Mercado
Ganancias

Global Forex and Fixed Income Roundup: Market Talk

2 mar 2026, 22:00 UTC

Charlas de Mercado
Ganancias

Fashion Retailer Hallenstein Glasson Still a Smart Buy -- Market Talk

2 mar 2026, 21:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Energy & Utilities Roundup: Market Talk

2 mar 2026, 21:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

2 mar 2026, 21:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

2 mar 2026, 21:35 UTC

Adquisiciones, fusiones, absorciones

AT&T Expects Net Debt-To-Adjusted Ebitda Ratio Will Rise to About 3.2x Following Deal With EchoStar and Decline to About 3x by End of 2026

2 mar 2026, 21:34 UTC

Adquisiciones, fusiones, absorciones

AT&T Remains on Track to Achieve Its 2026 and Multi-Yr Fincl Guidance

2 mar 2026, 21:30 UTC

Adquisiciones, fusiones, absorciones

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2 mar 2026, 21:17 UTC

Noticias de Eventos Importantes

Bank, Brokerage Stocks Recover Lost Ground After Last Week's Selloff -- Despite Iran Conflict -- Barrons.com

2 mar 2026, 20:44 UTC

Ganancias

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2 mar 2026, 20:43 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Treasury Yields Rise, Dollar Strengthens After Attack on Iran -- Market Talk

2 mar 2026, 20:28 UTC

Ganancias

Strategy Stock Rises. The World's Largest Bitcoin Holder Doubles Down on Its Crypto Bet. -- Barrons.com

2 mar 2026, 20:25 UTC

Charlas de Mercado
Noticias de Eventos Importantes

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

2 mar 2026, 20:24 UTC

Ganancias

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2 mar 2026, 20:14 UTC

Adquisiciones, fusiones, absorciones

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2 mar 2026, 20:12 UTC

Noticias de Eventos Importantes

Palantir Rises on Mideast Conflict. Why It's Moving Like a Defense Stock. -- Barrons.com

2 mar 2026, 20:08 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Global Forex and Fixed Income Roundup: Market Talk

2 mar 2026, 20:08 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Higher Oil Prices Could Boost Capex in Canada Energy Patch -- Market Talk

2 mar 2026, 20:05 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Oil Rises On U.S.-Middle East Conflict, But Settles Off Highs -- Market Talk

Comparación entre iguales

Cambio de precio

VistaGen Therapeutics Inc previsión

Precio Objetivo

By TipRanks

64.41% repunte

Estimación a 12 Meses

Media 0.97 USD  64.41%

Máximo 1 USD

Mínimo 0.9 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para VistaGen Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

5 ratings

0

Comprar

5

Mantener

0

Vender

Finanzas

$

help-icon Live chat